No Picture
Healthcare

Nova Mentis (OTC: NMLSF) Receives Health Canada Approval for First-Of-Its-Kind Psilocybin Clinical Trial

The human study will evaluate the Company’s proprietary psilocybin drug (NM-1001) in the treatment of Fragile X Syndrome Vancouver, British Columbia–(Newsfile Corp. – December 22, 2022) – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) […]

No Picture
Newsmakers

Nextech AR (OTC: NEXCF) Announces Plans For IPO Spin-Out Of 3D Design Studio Toggle3D, Targeting The $11 Billion CAD Market Shift to 3D-Commerce

Toggle3D is Nextech’s Second Spin-Out Following the Successful Debut of ARway TORONTO, Dec. 14, 2022 — Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) is pleased to announce today that […]

No Picture
Healthcare

Nova Mentis’ (OTC: NMLSF) Psilocybin Preclinical Study Published in International Science Journal

Microdose Treatment Modulates Cognition Vancouver, British Columbia— December 8, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and […]

Newsmakers

Nextech AR (OTC: NEXCF) CEO Evan Gappelberg Buys 250,000 Shares of Company Stock In Open Market Purchases

TORONTO, Nov. 29, 2022 — InvestorsHub NewsWire — Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: EP2), a Metaverse Company and leading provider of augmented reality (“AR”) experience technologies, wayfinding technologies and […]

Newsmakers

XTM (OTC: XTMIF) Q3 2022 Revenue Increases +70%

Revenue Up 70% and GDV 182% over Q3 2021 MIAMI & TORONTO, November 23, 2022—-XTM, Inc. (“XTM” or the “Company”) (QB: XTMIF / CSE:PAID / FSE:7XT), a Miami and Toronto-based Fintech innovator disseminating earned wages and providing […]

Healthcare

Nova (OTC: NMLSF) Submits Phase II A Psilocybin Clinical Trial Application to Health Canada

Microdose Psilocybin Safety and Efficacy Clinical Study in Fragile X Syndrome Vancouver, British Columbia– November 30, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and […]

Newsmakers

Nextech AR (OTC: NEXCF) Prepares Map D For Rapid Growth in 2023; Hires Industry Leading Executives, Positioning To Lead The Global Events Industry

Live Event Augmented Reality Wayfinding & XR Experiences Expected to Drive Triple Digit New Revenue Growth in 2023 TORONTO, November 22, 2022—-Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: EP2), a […]

CEO Interview

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) Leading in PSYCHEDELICS Pharma 🚀

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Potential for Autism and Other Neuroinflammatory Disorders” 9/7/22 NEXT SUPER STOCK: Nova Mentis Life Sciences […]

CEO Interview

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) NEW $7 Million Contract w AMAZON (& more 🐳 🐳 in pipeline) Plus: ARWay (CSE: ARWY) DEMO DAY! 9/8/22 livestream

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) NEW $7 Million Contract w AMAZON (& more 🐳 🐳 in pipeline)  PLUS: ARWay (CSE: ARWY) Demo Day 10/20/22 livestream NEXT SUPER STOCK NexTech AR (OTC: […]

CEO Interview

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) LIFTOFF! Web 3.0 + AR Exponential Growth Phase w Apple & Meta 9/8/22 livestream

  NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) LIFTOFF! Web 3.0 + AR Exponential Growth Phase w Apple & Meta 9/8/22 livestream   NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) Spinning […]

Healthcare

Nova Mentis (OTC: NMLSF) Enters into Research Contract with KGK Science for Phase II A Clinical Trial

Vancouver, British Columbia-November 17, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) (FSE: HN3Q) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders […]

Newsmakers

Nextech AR (OTC: NEXCF) Launches Breakthrough AI To Scale Its 3D Model Production Capabilities, Files New Patent

Nextech’s Breakthrough AI is aiming to solve the multi-billion dollar 3D model supply problem TORONTO, November 15, 2022—Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a Metaverse Company and […]